Latest Capital Management News

Page 7 of 328
Impact Minerals is shifting decisively towards Lake Hope’s high-purity alumina project after raising A$2.21 million and changing its leadership structure. The company now has A$2.61 million in cash, but still faces the more difficult task of funding pilot work, feasibility studies and eventual project development.
Victor Sage
Victor Sage
30 Oct 2026
Coppermoly ended the September quarter with $92,000 in cash and estimated funding for just 0.38 quarters of relevant outgoings. The mineral explorer is cutting costs, narrowing its Queensland portfolio and assessing potential funding and acquisition options after its managing director’s departure.
Maxwell Dee
Maxwell Dee
30 Oct 2026
InteliCare ended the September quarter with A$1.394 million in cash after an operating cash outflow of A$1.271 million, leaving just 1.10 quarters of estimated funding. The company is relying on customer receipts from expanding deployments, while continuing to assess funding options.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Gorilla Gold has extended high-grade mineralisation at Sovereign, Lakeview and Vivien, with Mineral Resource updates planned across its Western Australian projects by year-end. The exploration momentum comes with A$9.5 million in cash and less than one quarter of funding at the reported spending rate, leaving additional financing under consideration.
Maxwell Dee
Maxwell Dee
30 Oct 2026
EZZ Life Science cut its quarterly operating cash outflow sharply despite a 37.7% drop in customer receipts, as weaker Chinese e-commerce sales continued to weigh. EAORON skincare growth and a $9.16 million cash balance offer some support, but distributor collections and potential product returns remain unresolved.
Victor Sage
Victor Sage
30 Oct 2026
Rivco Australia has reported a 1.2% quarterly decline in pre-tax NAV as softer water entitlement values offset the benefits of a more heavily leased portfolio. The company is shifting dividends towards operating earnings, while continuing its buyback at a substantial discount to NAV.
Claire Turing
Claire Turing
30 Oct 2026
Riedel Resources has completed its transformation into a three-project gold explorer and is preparing to drill Cosmo in Western Australia for the first time since the 1990s. The company ended September with A$3.4 million in cash after a A$2.7 million equity raise, but its projected funding period is based on spending before the main drilling campaign begins.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Breakthrough Minerals has extended copper-gold mineralisation beyond Turpentine’s existing resource model, with its northernmost hole returning 14 metres at 1.57% CuEq. The exploration progress comes alongside A$2.484 million in cash and a reported 0.81 quarters of funding based on recent outgoings.
Maxwell Dee
Maxwell Dee
30 Oct 2026
I Synergy ended the September quarter with A$44,000 in cash and an estimated 0.76 quarters of funding, before securing A$200,000 in loan funding after quarter-end. Its proposed Macau digital economy partnership remains non-binding, while a prior half-year review flagged material uncertainty around going concern.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Desert Metals has agreed to sell its 80% stake in Tengrela South to Waraba Gold for up to A$5 million, giving the cash-poor explorer a potential non-dilutive funding bridge. The company will redirect its focus to drilling the undrilled Nyan gold corridor and exploring new Agboville permits in Côte d’Ivoire.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Eastern Gas has completed its Venus-2H horizontal appraisal well with 445 metres of interpreted coal contact, but the result now faces a more immediate test: whether the company can fund flow testing with only A$654,000 in cash. Gas deliverability remains unproven, while a proposed A$10 million R&D-backed facility is yet to be finalised.
Victor Sage
Victor Sage
30 Oct 2026
BCAL Diagnostics has completed clinical validation for BREASTESTplus 2 across all breast densities and is targeting a November launch, while expanding Avantect Multicancer access. The commercial push comes alongside $1.895 million in quarterly operating cash outflows, only $580,000 in cash at quarter end and a growing strategic stake in Genetic Signatures.
Ada Torres
Ada Torres
30 Oct 2026

Browse the archive

Full archive